What are the standard procedures and ICD-10 (International Classification of Diseases, 10th Revision) codes for a patient undergoing a sexually transmitted disease (STD) check, including tests for chlamydia, gonorrhea, syphilis, and Human Immunodeficiency Virus (HIV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Codes for Standard STD Screening Panel

The standard STD check includes testing for chlamydia, gonorrhea, syphilis, and HIV, with specific ICD-10 codes used for screening asymptomatic individuals versus diagnostic testing for those with symptoms or known exposures.

Primary Screening Codes for Asymptomatic Patients

Encounter Codes (Z-codes)

  • Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission 1, 2
  • Z11.4 - Encounter for screening for human immunodeficiency virus [HIV] 1, 2
  • Z11.59 - Encounter for screening for other viral diseases (for hepatitis B and C screening) 1, 2

Risk Factor Documentation Codes

  • Z72.51 - High-risk heterosexual behavior 1, 2
  • Z72.52 - High-risk homosexual behavior 1, 2
  • Z72.53 - High-risk bisexual behavior 1, 2
  • Z77.21 - Contact with and (suspected) exposure to potentially hazardous body fluids 1, 2

Standard Testing Components

Core STD Panel Tests

  • Chlamydia testing should use Z11.3 for screening in sexually active women ≤25 years or those with risk factors (new/multiple partners) 1, 2
  • Gonorrhea testing should use Z11.3 for screening in sexually active women <25 years and high-risk individuals 1, 2
  • HIV testing should use Z11.4 for all sexually active persons not in mutually monogamous relationships with uninfected partners 1, 2
  • Syphilis testing should use Z11.3 for individuals with high-risk sexual behavior or in high-prevalence communities 1, 2

Additional Tests Often Included

  • Hepatitis B screening uses Z11.59, particularly for pregnant women and high-risk individuals 1, 2
  • Hepatitis C screening uses Z11.59 based on risk factors 1, 2
  • Trichomoniasis testing uses Z11.3 for women with symptoms or high risk 1, 2

Site-Specific Testing Codes for High-Risk Populations

Men Who Have Sex with Men (MSM)

  • Use Z11.3 for urogenital, rectal, and pharyngeal chlamydia and gonorrhea testing based on reported sexual practices 3, 1, 2
  • Testing should occur at all three anatomic sites since infections are frequently asymptomatic and site-specific 3, 4

Pregnant Women

  • Use Z11.3 for chlamydia and gonorrhea if <25 years or at increased risk 3, 2
  • Use Z11.4 for universal HIV screening at first prenatal visit 3, 2
  • Use Z11.3 for syphilis screening at first prenatal visit, with repeat testing in third trimester and at delivery for high-risk women 3, 2
  • Use Z11.59 for hepatitis B surface antigen testing at first prenatal visit 3, 2

Diagnostic Codes When Symptoms Present

Critical distinction: Once symptoms develop or there is known exposure, testing becomes diagnostic rather than screening, requiring different ICD-10 codes 5:

  • A54.xx - Gonococcal infection codes (when symptomatic or contact)
  • A55 - Chlamydial lymphogranuloma (venereum)
  • A56.xx - Other sexually transmitted chlamydial diseases
  • A51.xx-A53.xx - Syphilis codes (various stages)
  • B20 - HIV disease
  • A59.xx - Trichomoniasis codes

Frequency-Based Coding Considerations

Annual Screening

  • Use Z11.3 or Z11.4 for routine annual screening in at-risk populations 1, 2
  • Document risk factors with Z72.51-Z72.53 codes to justify medical necessity 1, 2

High-Frequency Screening (Every 3-6 Months)

  • Use Z11.3 or Z11.4 with additional risk factor codes for individuals with ongoing high-risk behaviors including multiple partners, inconsistent condom use, or drug use during sex 3, 1, 2
  • HIV-infected individuals with high-risk behaviors warrant every 3-6 month testing regardless of previous negative results 3, 2

Post-Treatment Rescreening

  • Use Z09 (encounter for follow-up examination after completed treatment) combined with Z11.3 for mandatory 3-month retesting after chlamydia or gonorrhea treatment 1, 2
  • This rescreening is essential due to 25-40% reinfection rates 2

Common Coding Pitfalls to Avoid

  • Never use screening codes (Z11.x) when symptoms are present - this constitutes fraud and will result in claim denials 5
  • Document sexual history and risk factors to support medical necessity for screening frequency beyond annual intervals 3, 1
  • Use site-specific codes when billing for extragenital testing (rectal/pharyngeal) in MSM populations 3, 4
  • Ensure proper sequencing - list the screening code (Z11.x) as primary diagnosis, with risk factor codes (Z72.5x) as secondary 1, 2

Special Population Considerations

Adolescents and Young Adults

  • Z11.3 is appropriate for all sexually active women under 25 years for chlamydia and gonorrhea screening 1, 2
  • Higher infection rates in this age group due to more frequent partner changes and cervical immaturity justify routine screening 2

Persons Who Use Drugs

  • Use Z11.3 for routine screening for all common STIs including chlamydia, gonorrhea, syphilis, and trichomoniasis 2
  • Use Z11.59 for hepatitis C screening for all who inject drugs, even if only once 2

Correctional Facility Entrants

  • Use Z11.3 for screening persons entering correctional facilities for syphilis, gonorrhea, and chlamydia 2

References

Guideline

STD Screening Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

STD Testing and Treatment Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Screening Recommendations for HIV-Positive Patients with New Sexual Partners

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the recommended steps after a woman has protected sex with a stranger who has multiple sexual partners to prevent sexually transmitted infections (STIs)?
What is the recommended diagnostic workup for an 18-year-old male with asymptomatic bumps on his penis, suspected to be razor burn, and a history of chlamydia?
What screenings are most appropriate for a 23-year-old cisgender female with HIV (Human Immunodeficiency Virus) on Antiretroviral Therapy (ART) with a stable CD4 (Cluster of Differentiation 4) count and undetectable HIV RNA, who reports two new sexual partners since her last clinic visit?
What is the recommended STD testing and treatment for a 40-year-old female with a history of Trichomonas (Trich), recurrent Herpes Simplex Virus 2 (HSV-2) infections, and previous Gonorrhea (GC) and Chlamydia (CT) infections, who is asymptomatic but concerned about STD possibility after a recent condom break with a male partner of unknown history?
What are the recommendations for screening, prevention, and management of Sexually Transmitted and Blood-Borne Infections in high-risk patients?
What are the treatment options for a patient with a low Thyroid-Stimulating Hormone (TSH) level, indicating hyperthyroidism?
What are the next steps in managing a 24-year-old patient with fatty liver disease and elevated liver function tests (LFTs) (aspartate aminotransferase (AST) and alanine aminotransferase (ALT) of 134)?
What is the best treatment approach for a patient with a ruptured tympanic membrane (TM) and otitis externa, who is allergic to penicillin and fluoroquinolones?
Is the treatment of mesenteric ischemia based on catheterization (cath) or surgery?
What is the definition, classification, etiology, risk factors, epidemiology, pathogenesis, clinical presentation, diagnosis, diagnostic criteria, differential diagnosis, treatment, management, prevention, and recommendations for breast cysts in women, particularly those between 40 and 50 years old?
Can Mounjaro (tirzepatide) and Repatha (evolocumab) be administered on the same day in a patient with type 2 diabetes and high cholesterol, or should they be spaced out to minimize potential interactions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.